Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine

Summary

The purpose of this study is to determine whether administrating of Amantadine (a dopamine agonist) to patients suffering from Parkinson disease during the perioperative period is safe, and to asses potential benefits of this treatment.

Timeline

Start

2008-01

Primary completion

2011-07

Completion

2011-07

Outcome

Outcome not reported

Stopped: “PI leaving the institute for a fellowship.”

Publications

• Raz A, Lev N, Orbach-Zinger S, Djaldetti R. Safety of perioperative treatment with intravenous amantadine in patients with Parkinson disease. Clin Neuropharmacol. 2013 Sep-Oct;36(5):166-9. doi: 10.1097/WNF.0b013e31829bd066.

Drugs

Indications